182 related articles for article (PubMed ID: 30625021)
1. Impact of Peer Review on Use of Hypofractionated Regimens for Early-Stage Breast Cancer for Patients at a Tertiary Care Academic Medical Center and Its Community-Based Affiliates.
Ganju RG; TenNapel M; Chen AM; Mitchell M
J Oncol Pract; 2019 Feb; 15(2):e153-e161. PubMed ID: 30625021
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
Iocolano M; Wild AT; Hannum M; Zhang Z; Simone CB; Gelblum D; Wu AJ; Rimner A; Shepherd AF
Acta Oncol; 2020 Feb; 59(2):164-170. PubMed ID: 31608751
[No Abstract] [Full Text] [Related]
3. Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy.
McClelland S; Burney HN; Zellars RC; Ohri N; Rhome RM
Clin Breast Cancer; 2020 Dec; 20(6):469-479. PubMed ID: 32693964
[TBL] [Abstract][Full Text] [Related]
4. The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study.
Vamsi VS; Lukacova S; Dahlrot RH; Guldberg TL; Korshøj AR; Muhic A; Trip AK
Acta Oncol; 2023 Nov; 62(11):1511-1519. PubMed ID: 37558643
[TBL] [Abstract][Full Text] [Related]
5. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma.
Lyu J; Liu T; Li T; Li F; Wang Q; Wang J; Han Y; Wang J; Zhang J; Peng L; Lang J
Cancer Med; 2019 Jul; 8(8):3710-3718. PubMed ID: 31119872
[TBL] [Abstract][Full Text] [Related]
7. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials.
Lehrer EJ; Kishan AU; Yu JB; Trifiletti DM; Showalter TN; Ellis R; Zaorsky NG
Radiother Oncol; 2020 Jul; 148():235-242. PubMed ID: 32505965
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe - Results from an international survey.
Ratosa I; Chirilă ME; Steinacher M; Kozma E; Vojtíšek R; Franco P; Poortmans P
Radiother Oncol; 2021 Feb; 155():17-26. PubMed ID: 33065187
[TBL] [Abstract][Full Text] [Related]
9. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy.
Moradi LA; Schneider CS; Deshane AS; Popple RA; Kim RY; Marcrom SR
Radiat Oncol; 2022 Feb; 17(1):34. PubMed ID: 35164826
[TBL] [Abstract][Full Text] [Related]
11. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012.
Delaney GP; Gandhidasan S; Walton R; Terlich F; Baker D; Currow D
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):266-272. PubMed ID: 27473814
[TBL] [Abstract][Full Text] [Related]
12. Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.
Xiang M; Chang AJ; Chamie K; Drakaki A; Pollom EL; Steinberg ML; Kishan AU
Clin Genitourin Cancer; 2022 Apr; 20(2):e94-e103. PubMed ID: 34866018
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiation treatment in early breast cancer: Results in a New Zealand setting.
James ML; Dehn G; Robinson BA
Asia Pac J Clin Oncol; 2016 Sep; 12(3):248-53. PubMed ID: 26956225
[TBL] [Abstract][Full Text] [Related]
14. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.
Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E
Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer.
Yang J; Qi SN; Fang H; Song YW; Jin J; Liu YP; Wang WH; Yang Y; Tang Y; Ren H; Chen B; Lu NN; Tang Y; Li N; Jing H; Wang SL; Li YX
Breast; 2021 Aug; 58():72-79. PubMed ID: 33933925
[TBL] [Abstract][Full Text] [Related]
16. Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer.
Saeed NA; Jin L; Amini A; Verma V; Lester-Coll NH; Chen PH; Decker RH; Park HS
Am J Clin Oncol; 2023 Feb; 46(2):66-72. PubMed ID: 36662872
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
18. Choosing Wisely in radiation therapy for breast cancer: Time lag in adoption of hypofractionated radiation therapy in Victoria.
Ong WL; Khor R; Chao M; Milne RL; Millar J; Foroudi F
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):224-232. PubMed ID: 33591610
[TBL] [Abstract][Full Text] [Related]
19. Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy.
Sun GY; Wang SL; Song YW; Jin J; Wang WH; Liu YP; Ren H; Fang H; Tang Y; Zhao XR; Song YC; Yu ZH; Liu XF; Li YX
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):277-285. PubMed ID: 32147519
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
